Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714049 · ClinicalTrials.gov registry record · Phase 4
Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
A Phase 4 study, sponsored by San Diego Sexual Medicine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT02714049 is a Phase 4 study that was terminated before completion, run by San Diego Sexual Medicine. The registered enrollment target is 23 participants.
The verdict
NCT02714049, a Phase 4 study, was terminated before completion, sponsored by San Diego Sexual Medicine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 to receive study medication alone vs. study medication and sex therapy for 12 additional weeks.
Interventions
- DRUG flibanserin
- BEHAVIORAL sex therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-01-25 |
| Est. Completion | 2019-01-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02714049
The ClinicalTrials.gov registry entry for NCT02714049 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is San Diego Sexual Medicine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which flibanserin is the first listed.
NCT02714049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02714049 about?
NCT02714049 is a clinical study titled "Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy". Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 to receive study medication alone vs. study medication and sex therapy for 12 additional weeks.
What is the current status of trial NCT02714049?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2017-01-25. Estimated completion is 2019-01-30.
What interventions are being tested in trial NCT02714049?
The interventions under investigation include: flibanserin (DRUG), sex therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02714049?
This trial is sponsored by San Diego Sexual Medicine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.